Literature DB >> 34014532

Glutamine Metabolism in Cancer.

Ting Li1, Christopher Copeland1, Anne Le2,3.   

Abstract

Metabolism is a fundamental process for all cellular functions. For decades, there has been growing evidence of a relationship between metabolism and malignant cell proliferation. Unlike normal differentiated cells, cancer cells have reprogrammed metabolism in order to fulfill their energy requirements. These cells display crucial modifications in many metabolic pathways, such as glycolysis and glutaminolysis, which include the tricarboxylic acid (TCA) cycle, the electron transport chain (ETC), and the pentose phosphate pathway (PPP) [1]. Since the discovery of the Warburg effect, it has been shown that the metabolism of cancer cells plays a critical role in cancer survival and growth. More recent research suggests that the involvement of glutamine in cancer metabolism is more significant than previously thought. Glutamine, a nonessential amino acid with both amine and amide functional groups, is the most abundant amino acid circulating in the bloodstream [2]. This chapter discusses the characteristic features of glutamine metabolism in cancers and the therapeutic options to target glutamine metabolism for cancer treatment.

Entities:  

Keywords:  Glutamine addiction; Glutamine metabolism; Targeting amino acid synthesis; Targeting glutamine metabolism; Transaminase upregulation

Mesh:

Substances:

Year:  2021        PMID: 34014532     DOI: 10.1007/978-3-030-65768-0_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  127 in total

1.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.

Authors:  B E Baysal; R E Ferrell; J E Willett-Brozick; E C Lawrence; D Myssiorek; A Bosch; A van der Mey; P E Taschner; W S Rubinstein; E N Myers; C W Richard; C J Cornelisse; P Devilee; B Devlin
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Amino acid metabolism and its disorders.

Authors:  C R Scriver; L E Rosenberg
Journal:  Major Probl Clin Pediatr       Date:  1973

Review 3.  Regulation of cancer cell metabolism.

Authors:  Rob A Cairns; Isaac S Harris; Tak W Mak
Journal:  Nat Rev Cancer       Date:  2011-02       Impact factor: 60.716

Review 4.  SDH mutations in cancer.

Authors:  Chiara Bardella; Patrick J Pollard; Ian Tomlinson
Journal:  Biochim Biophys Acta       Date:  2011-07-13

5.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.

Authors:  B E Baysal; J E Willett-Brozick; E C Lawrence; C M Drovdlic; S A Savul; D R McLeod; H A Yee; D E Brackmann; W H Slattery; E N Myers; R E Ferrell; W S Rubinstein
Journal:  J Med Genet       Date:  2002-03       Impact factor: 6.318

Review 6.  Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells.

Authors:  Jin-Qiang Chen; Jose Russo
Journal:  Biochim Biophys Acta       Date:  2012-06-27

Review 7.  Isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH): three players for one phenotype in cancer?

Authors:  Giulio Laurenti; Daniel A Tennant
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

Review 8.  Citric acid cycle and role of its intermediates in metabolism.

Authors:  Muhammad Akram
Journal:  Cell Biochem Biophys       Date:  2014-04       Impact factor: 2.194

Review 9.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

10.  TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State.

Authors:  Simone Cardaci; Maria Rosa Ciriolo
Journal:  Int J Cell Biol       Date:  2012-07-19
View more
  3 in total

Review 1.  Metabolic changes during prostate cancer development and progression.

Authors:  Alicia-Marie K Beier; Martin Puhr; Matthias B Stope; Christian Thomas; Holger H H Erb
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-23       Impact factor: 4.322

Review 2.  Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward.

Authors:  Asimina Zisi; Jiri Bartek; Mikael S Lindström
Journal:  Cancers (Basel)       Date:  2022-04-24       Impact factor: 6.575

3.  A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs.

Authors:  De-Bin Ma; Xing-Yu Liu; Hui Jia; Yingshi Zhang; Qiyu Jiang; Huiwei Sun; Xiaojuan Li; Fang Sun; Yantao Chai; Fan Feng; Lei Liu
Journal:  Front Pharmacol       Date:  2022-05-18       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.